These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9679951

  • 21. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
    Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM.
    Cancer Res; 2001 Feb 15; 61(4):1578-84. PubMed ID: 11245468
    [Abstract] [Full Text] [Related]

  • 22. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.
    Wang L, Darling J, Zhang JS, Qian CP, Hartmann L, Conover C, Jenkins R, Smith DI.
    Oncogene; 1998 Feb 05; 16(5):635-42. PubMed ID: 9482109
    [Abstract] [Full Text] [Related]

  • 23. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
    Lee SH, Kim TJ, Kim HY, Kim JG, Park MK, Woo KM, Kim SH, Hwang KY, Nam HS, Min YK, Cho MH.
    Res Commun Mol Pathol Pharmacol; 2002 Feb 05; 112(1-4):145-57. PubMed ID: 15080505
    [Abstract] [Full Text] [Related]

  • 24. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z, Lele SM, Rampy BA, Norris BA.
    Cancer; 2000 Mar 15; 88(6):1378-83. PubMed ID: 10717620
    [Abstract] [Full Text] [Related]

  • 25. Inactivation of the FHIT gene favors bladder cancer development.
    Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R.
    Clin Cancer Res; 2004 Nov 15; 10(22):7607-12. PubMed ID: 15569992
    [Abstract] [Full Text] [Related]

  • 26. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW, Le Beau MM.
    Cancer Res; 2002 Jun 15; 62(12):3477-84. PubMed ID: 12067991
    [Abstract] [Full Text] [Related]

  • 27. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K.
    Cancer Res; 1997 Feb 01; 57(3):504-12. PubMed ID: 9012482
    [Abstract] [Full Text] [Related]

  • 28. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B, Bartsch D, Barth P, Prasnikar N, Münch K, Blum A, Arnold R, Göke B.
    Cancer Res; 1998 Apr 15; 58(8):1583-7. PubMed ID: 9563464
    [Abstract] [Full Text] [Related]

  • 29. The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma.
    Luan X, Shi G, Zohouri M, Paradee W, Smith DI, Decker HJ, Cannizzaro LA.
    Oncogene; 1997 Jul 03; 15(1):79-86. PubMed ID: 9233780
    [Abstract] [Full Text] [Related]

  • 30. Loss or reduction of Fhit expression in renal neoplasias: correlation with histogenic class.
    Hadaczek P, Kovatich A, Gronwald J, Lubinski J, Huebner K, McCue PA.
    Hum Pathol; 1999 Nov 03; 30(11):1276-83. PubMed ID: 10571505
    [Abstract] [Full Text] [Related]

  • 31. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 32. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 33. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID, Szeles A, Yang Y, Klein G, Imreh S.
    Cancer Res; 2000 Dec 15; 60(24):7119-25. PubMed ID: 11156420
    [Abstract] [Full Text] [Related]

  • 34. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T, Sasagawa T, Yamazaki H, Sakaike J, Ishikawa H, Inoue M.
    Cancer; 1999 May 01; 85(9):2001-10. PubMed ID: 10223242
    [Abstract] [Full Text] [Related]

  • 35. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas.
    Hilgers W, Groot Koerkamp B, Geradts J, Tang DJ, Yeo CJ, Hruban RH, Kern SE.
    Genes Chromosomes Cancer; 2000 Mar 01; 27(3):239-43. PubMed ID: 10679912
    [Abstract] [Full Text] [Related]

  • 36. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.
    Am J Surg Pathol; 2007 Oct 01; 31(10):1528-33. PubMed ID: 17895753
    [Abstract] [Full Text] [Related]

  • 37. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
    Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG.
    Cancer Res; 1998 Aug 01; 58(15):3409-14. PubMed ID: 9699673
    [Abstract] [Full Text] [Related]

  • 38. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.
    Hao XP, Willis JE, Pretlow TG, Rao JS, MacLennan GT, Talbot IC, Pretlow TP.
    Cancer Res; 2000 Jan 01; 60(1):18-21. PubMed ID: 10646844
    [Abstract] [Full Text] [Related]

  • 39. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K, Cheale M, Coleman N, Fox SB.
    Clin Cancer Res; 2002 Apr 01; 8(4):1075-81. PubMed ID: 11948116
    [Abstract] [Full Text] [Related]

  • 40. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
    Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM.
    Cancer Res; 2000 Mar 01; 60(5):1177-82. PubMed ID: 10728669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.